On Tuesday, Health Catalyst Inc (NASDAQ: HCAT) opened lower -4.35% from the last session, before settling in for the closing price of $5.75. Price fluctuations for HCAT have ranged from $5.32 to $10.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 17.83% annually for the last half of the decade. Company’s average yearly earnings per share was noted 108.21% at the time writing. With a float of $58.25 million, this company’s outstanding shares have now reached $60.85 million.
In an organization with 1300 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 35.68%, operating margin of -21.37%, and the pretax margin is -26.25%.
Health Catalyst Inc (HCAT) Insider Updates
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Health Catalyst Inc is 4.26%, while institutional ownership is 89.64%. The most recent insider transaction that took place on Feb 05 ’25, was worth 30,007. In this transaction Chief Operating Officer of this company sold 5,209 shares at a rate of $5.76, taking the stock ownership to the 86,044 shares. Before that another transaction happened on Feb 05 ’25, when Company’s Officer proposed sale 5,209 for $5.62, making the entire transaction worth $29,275.
Health Catalyst Inc (HCAT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 108.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.80% during the next five years compared to 7.69% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Check out the current performance indicators for Health Catalyst Inc (HCAT). In the past quarter, the stock posted a quick ratio of 1.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.69 million. That was inferior than the volume of 0.79 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 56.88%. Additionally, its Average True Range was 0.35.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 4.59%, which indicates a significant decrease from 29.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.82% in the past 14 days, which was lower than the 56.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.84, while its 200-day Moving Average is $7.14. However, in the short run, Health Catalyst Inc’s stock first resistance to watch stands at $5.63. Second resistance stands at $5.75. The third major resistance level sits at $5.84. If the price goes on to break the first support level at $5.41, it is likely to go to the next support level at $5.32. Assuming the price breaks the second support level, the third support level stands at $5.20.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
There are currently 60,848K shares outstanding in the company with a market cap of 334.66 million. Presently, the company’s annual sales total 295,940 K according to its annual income of -118,150 K. Last quarter, the company’s sales amounted to 76,350 K and its income totaled -14,730 K.
